Yale School of Medicine and FDA’s Office of Minority Health and Health Equity Diversity Day: Patient Centered Approach to Care and Research
The Innovation and Diversity Summit: Patient-Centered Approaches to Care and Research, a collaboration of Yale School of Medicine and our partners at the FDA Office of Minority Health and Health Equity and the YCCI Cultural Ambassadors for Clinical Research, will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas. This is the second event in a series of summits to focus on these issues. Our goal is to bring stakeholders from the governmental agencies, industry, academia, and community to provoke discussion about innovation and clinical trial diversity and raise awareness.
Distinguished speakers include Gary H. Gibbons, MD, Director, National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH); Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), FDA; CAPT Richardae Araojo, Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE), FDA; RADM Denise Hinton, Chief Scientist, FDA; Dr. Fabian Sandoval, CEO & Research Director, Emerson Clinical Research Institute (ECRI) and Emerson Diversity Health Foundation; Dr. Nancy Brown, Dean, Yale School of Medicine; Dr. Brian Smith, Deputy Dean for Scientific Affairs (Clinical Departments), Chair, Department of Laboratory Medicine, Co-Director, YCCI; Dr. John Krystal, Chair, Department of Psychiatry, Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital, Co-Director, YCCI; Dr. Allen Hsiao, Chief Medical Information Officer, Yale School of Medicine & Yale New Haven Health; and Tesheia Johnson, MBA, MHS, Deputy Director and Chief Operating Officer of YCCI, Associate Director for Clinical Research for Yale School of Medicine.